EyePoint Pharmaceuticals Inc (NASDAQ:EYPT)

9.11
Delayed Data
As of 3:59pm ET
 +0.41 / +4.71%
Today’s Change
3.51
Today|||52-Week Range
15.06
+38.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$232.9M

Company Description

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

Contact Information

EyePoint Pharmaceuticals, Inc.
480 Pleasant Street
Watertown Massachusetts 02472
P:(617) 926-5000
Investor Relations:

Employees

Shareholders

Other institutional25.87%
Mutual fund holders23.94%
Individual stakeholders11.03%

Top Executives

Nancy Sue LurkerPresident, Chief Executive Officer & Director
George O. ElstonCFO & Head-Corporate Development
Dario A. PaggiarinoChief Medical Officer & Senior Vice President
Jay S. DukerChief Strategic Scientific Officer
Said SaimChief Technology Officer